Addressing a clear unmet medical need in the personalized adjuvant treatment of early-stage breast cancer.
Barcelona
Joined January 2021
- Tweets1
- Following36
- Followers48
- Likes0
Inbiomotion’s MAF Test® selects breast cancer patients benefitting from adjuvant clodronate, significantly improving their overall survival. inbiomotion.com/news/